Skip to content
ChickenStockChickenStock
ResearchPCVX
Vaxcyte logo

Vaxcyte (PCVX) stock

NASDAQ

$59.46-3.49%(-2.15)

As of the Nov 17, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-8.18x

Net loss — not comparable

P/B

3.77x

P/S

—

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Operating income decreased from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 4, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

40 SEC filings
  • Dhaliwal Harpreet S.Chief Technical Ops Officer · Nov 11, 2026Open-market sale17,000 shares · $1.2M
    Avg. price $67.8296
    Show 3 price lots
    • 9,345 shares × $68.156$637K
    • 7,135 shares × $67.33$480K
    • 520 shares × $68.819$36K
  • Dhaliwal Harpreet S.Chief Technical Ops Officer · Nov 11, 2026Option exercise17,000 shares · $421K
    Avg. price $24.7985,085 shares held after
  • Cowan ElviaSVP, Finance & CAO · Nov 2, 2026Open-market sale3,000 shares · $183K
    Avg. price $60.9178
    Show 2 price lots
    • 2,414 shares × $60.765$147K
    • 586 shares × $61.547$36K
  • Wassil JimEVP, Chief Scientific Ofc, COO · Nov 2, 2026Open-market sale2,250 shares · $137K
    Avg. price $60.8996
    Show 2 price lots
    • 1,907 shares × $60.779$116K
    • 343 shares × $61.57$21K
  • Cowan ElviaSVP, Finance & CAO · Nov 2, 2026Option exercise3,000 shares · $78K
    Avg. price $25.9230,860 shares held after
  • Wassil JimEVP, Chief Scientific Ofc, COO · Nov 2, 2026Option exercise2,250 shares · $12K
    Avg. price $5.35147,685 shares held after
  • Cowan ElviaSVP, Finance & CAO · Oct 5, 2026Open-market sale19,000 shares · $1.6M
    Avg. price $86.7427,860 shares held after
  • Wassil JimEVP, Chief Scientific Ofc, COO · Oct 5, 2026Open-market sale18,000 shares · $1.6M
    Avg. price $86.74145,435 shares held after
  • Cowan ElviaSVP, Finance & CAO · Oct 5, 2026Option exercise19,000 shares · $492K
    Avg. price $25.9246,860 shares held after
  • Wassil JimEVP, Chief Scientific Ofc, COO · Oct 5, 2026Option exercise18,000 shares · $96K
    Avg. price $5.35163,435 shares held after
  • Wassil JimEVP, Chief Scientific Ofc, COO · Oct 1, 2026Open-market sale2,250 shares · $128K
    Avg. price $56.6726
    Show 2 price lots
    • 2,155 shares × $56.654$122K
    • 95 shares × $57.094$5K
  • Wassil JimEVP, Chief Scientific Ofc, COO · Oct 1, 2026Option exercise2,250 shares · $12K
    Avg. price $5.35147,685 shares held after
  • Wassil JimEVP, Chief Scientific Ofc, COO · Sep 9, 2026Open-market sale1,334 shares · $79K
    Avg. price $59.521145,435 shares held after
  • PICKERING GRANTCHIEF EXECUTIVE OFFICER · Sep 8, 2026Shares withheld for taxes17,056 shares · $1.0M
    Avg. price $60.36429,902 shares held after
  • Dhaliwal Harpreet S.Chief Technical Ops Officer · Sep 8, 2026Shares withheld for taxes7,651 shares · $462K
    Avg. price $60.3668,085 shares held after
  • GUGGENHIME ANDREWPRESIDENT AND CFO · Sep 8, 2026Shares withheld for taxes7,155 shares · $432K
    Avg. price $60.3695,316 shares held after
  • Wassil JimEVP, Chief Scientific Ofc, COO · Sep 8, 2026Shares withheld for taxes5,459 shares · $330K
    Avg. price $60.36146,769 shares held after
  • Cowan ElviaSVP, Finance & CAO · Sep 8, 2026Shares withheld for taxes1,327 shares · $80K
    Avg. price $60.3627,860 shares held after
  • Wassil JimEVP, Chief Scientific Ofc, COO · Sep 4, 2026Open-market sale1,381 shares · $84K
    Avg. price $61.16152,228 shares held after
  • Jodar LuisChief Medical Officer · Sep 4, 2026Grant or award52,632 shares · $0
    Avg. price $052,632 shares held after
  • PICKERING GRANTCHIEF EXECUTIVE OFFICER · Sep 2, 2026Shares withheld for taxes3,427 shares · $211K
    Avg. price $61.58446,958 shares held after
  • GUGGENHIME ANDREWPRESIDENT AND CFO · Sep 2, 2026Shares withheld for taxes1,432 shares · $88K
    Avg. price $61.58102,471 shares held after
  • Wassil JimCHIEF OPERATING OFFICER · Sep 2, 2026Shares withheld for taxes1,432 shares · $88K
    Avg. price $61.58153,609 shares held after
  • Dhaliwal Harpreet S.Chief Technical Ops Officer · Sep 2, 2026Shares withheld for taxes659 shares · $41K
    Avg. price $61.5875,736 shares held after
  • Cowan ElviaSVP, Finance & CAO · Sep 2, 2026Shares withheld for taxes326 shares · $20K
    Avg. price $61.5829,187 shares held after
  • Wassil JimCHIEF OPERATING OFFICER · Sep 1, 2026Open-market sale3,477 shares · $212K
    Avg. price $61.0732
    Show 4 price lots
    • 1,537 shares × $60.886$94K
    • 924 shares × $60.955$56K
    • 713 shares × $61.481$44K
    • 303 shares × $61.424$19K
  • Wassil JimCHIEF OPERATING OFFICER · Sep 1, 2026Option exercise2,250 shares · $12K
    Avg. price $5.35158,518 shares held after
  • PICKERING GRANTCHIEF EXECUTIVE OFFICER · Aug 31, 2026Shares withheld for taxes2,862 shares · $174K
    Avg. price $60.74450,385 shares held after
  • Wassil JimCHIEF OPERATING OFFICER · Aug 31, 2026Shares withheld for taxes1,273 shares · $77K
    Avg. price $60.74156,268 shares held after
  • GUGGENHIME ANDREWPRESIDENT AND CFO · Aug 31, 2026Shares withheld for taxes1,273 shares · $77K
    Avg. price $60.74103,903 shares held after
  • Dhaliwal Harpreet S.Chief Technical Ops Officer · Aug 31, 2026Shares withheld for taxes361 shares · $22K
    Avg. price $60.7476,395 shares held after
  • Cowan ElviaSVP, Finance & CAO · Aug 31, 2026Shares withheld for taxes243 shares · $15K
    Avg. price $60.7429,513 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Vaxcyte (PCVX) stock information

NASDAQ

Vaxcyte (PCVX) is listed on NASDAQ. Its market capitalization is about $9.4B. On trailing-twelve-month earnings the P/E ratio is -8.18, and the P/B ratio is 3.77. Return on equity is -46.1%. These figures are computed in-house from official filings and are reference information only.

Vaxcyte — frequently asked questions

What is the P/E ratio of Vaxcyte (PCVX)?
On a trailing-twelve-month basis, PCVX trades at a P/E ratio of -8.18. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Vaxcyte?
PCVX has a market capitalization of about $9.4B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.